0001161697-23-000629.txt : 20231219
0001161697-23-000629.hdr.sgml : 20231219
20231219170018
ACCESSION NUMBER: 0001161697-23-000629
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231215
FILED AS OF DATE: 20231219
DATE AS OF CHANGE: 20231219
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Harper Molly
CENTRAL INDEX KEY: 0001871470
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33057
FILM NUMBER: 231498234
MAIL ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001369568
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
BUSINESS PHONE: (305) 529-2522
MAIL ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
FORMER COMPANY:
FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC.
DATE OF NAME CHANGE: 20110215
FORMER COMPANY:
FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc.
DATE OF NAME CHANGE: 20060719
4
1
form_4.xml
FORM 4 FOR 12-15-2023
X0508
4
2023-12-15
0
0001369568
CATALYST PHARMACEUTICALS, INC.
CPRX
0001871470
Harper Molly
355 ALHAMBRA CIRCLE
SUITE 801
CORAL GABLES
FL
33134
1
0
0
0
0
Common stock, par value $0.001 per share
2023-12-15
4
S
0
4000
14.43
D
0
D
Common stock, par value $0.001 per share
2023-12-15
4
M
0
10000
5.78
A
10000
D
Common stock, par value $0.001 per share
2023-12-15
4
S
0
10000
14.37
D
0
D
Options to purchase common stock
5.78
2023-12-15
4
M
0
10000
0
D
2028-06-29
Common Stock
10000
130764
D
Shares were sold on the open market for personal reasons and to fund the exercise price of the stock options, and not as a result of any disagreement with the Company.
Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $14.37 to $14.40 per share.
Options vest in three annual tranches beginning on June 29, 2022.
/s/ Molly Harper
2023-12-19